Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
Authors:
- P.C. BaierPBP.C. Baier
- M. HallschmidMHM. Hallschmid
- M. Seeck-HirschnerMSM. Seeck-Hirschner
- S.L. WeinholdSWS.L. Weinhold
- S. BurkertSBS. Burkert
- N. DiessnerNDN. Diessner
- R. GöderRGR. Göder
- J.B. AldenhoffJAJ.B. Aldenhoff
- D. Hinze-SelchDHD. Hinze-Selch
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 12 (10) , 941-946
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 654/B6)
This publication has 37 references indexed in Scilit:
- Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?Brain, 2010
- Validation of the ICSD-2 Criteria for CSF Hypocretin-1 Measurements in the Diagnosis of Narcolepsy in the Danish PopulationSLEEP, 2010
- Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiencyBrain, 2010
- Localized Loss of Hypocretin (Orexin) Cells in Narcolepsy Without CataplexySLEEP, 2009
- Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward SystemPharmacological Reviews, 2009
- Narcolepsy is strongly associated with the T-cell receptor alpha locusNature Genetics, 2009
- The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other HypersomniasArchives of Neurology, 2002
- Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and ObesityNeuron, 2001
- A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNature Medicine, 2000
- Narcolepsy in orexin Knockout MiceCell, 1999